Effects of Nature-Based Virtual Reality and Binaural Beats on Heart Rate Variability and Relaxation
VRELAX
2 other identifiers
interventional
18
0 countries
N/A
Brief Summary
The VRELAX study is a non-clinical sub-study within the "Decreasing Preoperative Stress to Prevent Postoperative Delirium and Postoperative Cognitive Decline in Cardiac Surgical Patients"- research program (DESTRESS; NCT05036538), which investigates non-pharmacological relaxation interventions using virtual reality and binaural auditory stimulation. In a randomized counterbalanced within-subject design, non-clinical adult participants complete two sessions separated by a 1 day intervention-free interval. A 30-minute immersive nature-based virtual reality exposure combined with gradually decreasing binaural beats (10-1 Hertz (Hz)), and a control condition without relaxation. Heart rate variability (HRV) is recorded continuously, and subjective stress is assessed before and after each condition. The primary outcome is parasympathetic activation operationalized as high-frequency (HF) power of heart rate variability. Secondary outcomes include additional HRV parameters and self-reported stress ratings. The study aims to characterize short-term relaxation effects and evaluate the feasibility of independent use in everyday settings, supporting interpretation of clinical findings of the DESTRESS trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2026
CompletedFirst Posted
Study publicly available on registry
February 25, 2026
CompletedStudy Start
First participant enrolled
February 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 20, 2026
February 25, 2026
February 1, 2026
10 months
February 5, 2026
February 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in High-Frequency Power of Heart Rate Variability (HF Power)
Spectral power in the high-frequency band (0.15-0.40 Hz) of heart rate variability measured in ms². Higher values reflect greater parasympathetic activity. The primary outcome is defined as the pre- to post-intervention change in HF-HRV measured continuously during the intervention or control condition.
Pre- and post-intervention within a single 30-minute study session
Secondary Outcomes (5)
Change in Root Mean Square of Successive Differences (RMSSD)
Pre- and post-intervention within a single 30-minute study session
Change in Number of Successive NN Interval Differences Greater Than 50 ms (NN50)
Pre- and post-intervention within a single 30-minute study session
Change in Proportion of NN50 (pNN50)
Pre- and post-intervention within a single 30-minute study session
Change in Relative High-Frequency Power (HF%)
Pre- and post-intervention within a single 30-minute study session
Change in Self-Reported Stress (Visual Analog Scale)
Pre- and post-intervention within a single 30-minute study session
Other Outcomes (2)
Successful independent completion of the intervention based on pictorial instructions
Postprocedural / Postintervention. Immediately at the end of the 30-minute intervention session
Usability rating of the pictorial instruction
Postprocedual / Postintervention. Within 5 minutes after the end of the 30-minute intervention session.
Study Arms (2)
VR + Binaural Beats
EXPERIMENTALParticipants receive a 30-minute immersive nature-based virtual reality relaxation intervention combined with binaural beats.
Control Condition
NO INTERVENTIONParticipants undergo a control condition involving everyday cognitive activities without relaxation intervention.
Interventions
A 30-minute immersive virtual reality exposure to natural environments combined with binaural auditory stimulation gradually decreasing from alpha to delta frequency range (10-1 Hz).
Eligibility Criteria
You may qualify if:
- Adults aged 18 years or older
- Ability to understand study procedures and provide written informed consent
- Sufficient proficiency in the German language to complete questionnaires and follow study instructions
- Willingness to participate in a single approximately 60-minute study session
You may not qualify if:
- Current or history of neurological or psychiatric disorders that may interfere with data collection (e.g., dementia, major depressive disorder, stroke, epilepsy)
- Severe visual or hearing impairments that would limit the use of virtual reality equipment or headphones
- History of adverse reactions to virtual reality
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Nicole Schmidt-Bodensohn, PhD, M.Sc.
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- This is an open-label study. Due to the nature of the interventions, participants and investigators are not blinded to group assignment.
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 5, 2026
First Posted
February 25, 2026
Study Start
February 25, 2026
Primary Completion (Estimated)
December 20, 2026
Study Completion (Estimated)
December 20, 2026
Last Updated
February 25, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share